Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circadian disruption and cisplatin chronotherapy for mammary carcinoma

Toxicology and Applied Pharmacology(2022)10.1016/j.taap.2022.115863Source: DataRank Database

Circadian disruption and cisplatin chronotherapy for mammary carcinoma is a research paper published in Toxicology and Applied Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.28)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Kenneth I Porter,Soumyadeep Sarkar ORCID,Shobhan Gaddameedhi ORCID,Bala S. C. Koritala ORCID

Live enrichment

PubMed:34998857 PMC:PMC8792356 OpenAlex:https://openalex.org/W4206770629

Congressionally Directed Medical Research Programs

Grant: W81XWH-18-1-0061

National Institutes of Health

Grant: R01ES030113

National Institutes of Health

Grant: R21CA227381

University of Florida

FWCI

1.28

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8792356

publisherhttps://api.elsevier.com/content/article/PII:S0041008X22000023?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0041008X22000023?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.taap.2022.115863

Fields of Study

Circadian rhythm and melatoninLight effects on plantsEstrogen and related hormone effectsAnimalsBreast NeoplasmsCell LineChronotherapyCircadian ClocksCircadian RhythmCisplatinFemaleHEK293 CellsHumansMammary Neoplasms, AnimalMiceMice, Inbred NOD

MeSH Terms

AnimalsBreast NeoplasmsCell LineCircadian RhythmCisplatinFemaleHumansMammary Neoplasms, AnimalMice, Inbred NODChronotherapyMiceHEK293 CellsCircadian Clocks

Keywords

Chronotherapy (sleep phase)CisplatinCircadian clockCircadian rhythmInternal medicineEndocrinologyMedicineCancerMammary carcinomaCarcinomaBiologyChemotherapyBreast cancerChronotherapyClock Disruption

Sustainable Development Goals

SDG 0: Good health and well-being